Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer

INTRODUCTION: To evaluate the efficacy of cytoreductive surgery versus chemotherapy for the treatment of limited regional, platinum-resistant ovarian cancer (PROC). MATERIALS AND METHODS: The clinical records of all patients with PROC treated in our center between March 2015 and March 2022 were retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Ruoyao, Jiang, Qidi, Luo, Xukai, Chen, Mo, Yuan, Lei, Yao, Liangqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688147/
https://www.ncbi.nlm.nih.gov/pubmed/38037085
http://dx.doi.org/10.1186/s12957-023-03230-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688147/
https://www.ncbi.nlm.nih.gov/pubmed/38037085
http://dx.doi.org/10.1186/s12957-023-03230-3

Ejemplares similares